These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33175110)

  • 61. Race to find COVID-19 treatments accelerates.
    Kupferschmidt K; Cohen J
    Science; 2020 Mar; 367(6485):1412-1413. PubMed ID: 32217705
    [No Abstract]   [Full Text] [Related]  

  • 62. COVID-19: Rescue by transcriptional inhibition.
    Shilatifard A
    Sci Adv; 2020 Jul; 6(27):. PubMed ID: 32937442
    [No Abstract]   [Full Text] [Related]  

  • 63. Use of remdesivir for patients with Covid-19: a review article.
    Azevedo TCP; Azevedo PCP; Silveira Filho RN; Carvalho ARVS; Cezarotti Filho ML; Barbosa FT; Sousa-Rodrigues CF; Matos-Rocha TJ; Ramos FWDS
    Rev Assoc Med Bras (1992); 2020 Jun; 66(6):838-841. PubMed ID: 32696862
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Estimating the effectiveness of remdesivir on risk of COVID-19 mortality: The role of observational data.
    Giacomelli A; Cozzi-Lepri A; Casalini G; Oreni L; Ridolfo AL; Antinori S
    Pharmacol Res; 2022 Jul; 181():106268. PubMed ID: 35605811
    [No Abstract]   [Full Text] [Related]  

  • 65. Remdesivir improved time to recovery in adults hospitalized with COVID-19 and lower respiratory tract involvement.
    Paladugu S; Donato AA
    Ann Intern Med; 2020 Jul; 173(2):JC4. PubMed ID: 32687756
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Remdesivir for patients with COVID-19].
    Augustin M; Hallek M; Nitschmann S
    Internist (Berl); 2020 Aug; 61(8):869-872. PubMed ID: 32572516
    [No Abstract]   [Full Text] [Related]  

  • 67. Successful early treatment combining remdesivir with high-titer convalescent plasma among COVID-19-infected hematological patients.
    Weinbergerova B; Mayer J; Kabut T; Hrabovsky S; Prochazkova J; Kral Z; Herout V; Pacasova R; Zdrazilova-Dubska L; Husa P; Bednar P; Ruzek D; Lengerova M
    Hematol Oncol; 2021 Dec; 39(5):715-720. PubMed ID: 34396566
    [No Abstract]   [Full Text] [Related]  

  • 68. USA stockpiling of remdesivir: How should the world respond?
    Dawoud D; Chalkidou K; Sullivan R; Ruiz FJ; Adler A
    J Comp Eff Res; 2020 Dec; 9(18):1243-1246. PubMed ID: 33274643
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Remdesivir: A giant step, or a tiptoe?
    Dickinson GM
    Clin Dermatol; 2020; 38(6):773-774. PubMed ID: 32405143
    [No Abstract]   [Full Text] [Related]  

  • 70. Streptococcus pneumoniae coinfection in hospitalised patients with COVID-19.
    Anton-Vazquez V; Clivillé R
    Eur J Clin Microbiol Infect Dis; 2021 Jun; 40(6):1353-1355. PubMed ID: 33462723
    [No Abstract]   [Full Text] [Related]  

  • 71. Coronavirus Disease (COVID-19) Pandemic: A Race Against Time.
    Banerjee AK; Arora N
    Curr Top Med Chem; 2020; 20(16):1434-1437. PubMed ID: 32282303
    [No Abstract]   [Full Text] [Related]  

  • 72. Leaks of Clinical Trial Data and Research Integrity.
    Rajkumar SV; Sampathkumar P
    Mayo Clin Proc; 2020 Jul; 95(7):1318-1319. PubMed ID: 32622439
    [No Abstract]   [Full Text] [Related]  

  • 73. Audio Interview: New Data on Remdesivir in Covid-19.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2020 May; 382(22):e94. PubMed ID: 32459948
    [No Abstract]   [Full Text] [Related]  

  • 74. Remdesivir: A beacon of hope from Ebola virus disease to COVID-19.
    Nili A; Farbod A; Neishabouri A; Mozafarihashjin M; Tavakolpour S; Mahmoudi H
    Rev Med Virol; 2020 Nov; 30(6):1-13. PubMed ID: 33210457
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Hydroxychloroquine and Remdesivir in COVID-19: A critical analysis of recent events.
    Dang A; Vallish BN; Dang S
    Indian J Med Ethics; 2020; V(3):202-207. PubMed ID: 33295289
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [The medicinal treatment of COVID-19: a brief update].
    de Boer MGJ; Gieling EM; van der Linden PD; Sinha BNM; Vollaard AM
    Ned Tijdschr Geneeskd; 2020 Nov; 164():. PubMed ID: 33331727
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Use of Remdesivir in Myasthenia gravis and COVID-19.
    Peters BJ; Rabinstein AA; DuBrock HM
    Pharmacotherapy; 2021 Jun; 41(6):546-550. PubMed ID: 33835512
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Remdesivir as a broad-spectrum antiviral drug against COVID-19.
    Hong YN; Xu J; Sasa GBK; Zhou KX; Ding XF
    Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):541-548. PubMed ID: 33506946
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Rapid review for the anti-coronavirus effect of remdesivir.
    Li Z; Wang X; Cao D; Sun R; Li C; Li G
    Drug Discov Ther; 2020; 14(2):73-76. PubMed ID: 32378648
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Immune responses and therapeutic challenges in paediatric patients with new-onset acute myeloid leukaemia and concomitant COVID-19.
    Patel PA; Lapp SA; Grubbs G; Edara VV; Rostad CA; Stokes CL; Pauly MG; Anderson EJ; Piantadosi A; Suthar MS; Khurana S; Sabnis HS
    Br J Haematol; 2021 Aug; 194(3):549-553. PubMed ID: 34096051
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.